- Written by ClinicalTrials.gov
- Category: Spine Diseases
Interventions: Drug: Tofacitinib (CP-690,550); Drug: Tofacitinib (CP-690,550); Drug: Placebo; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified August 2011
- Details
Improving orthopaedic care, education and research using Internet technologies
© 1999-2017 Orthogate. All rights reserved.